{"id":"NCT02981446","sponsor":"Santen Pharmaceutical Co., Ltd.","briefTitle":"A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT","officialTitle":"A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% Compared With Latanoprost Ophthalmic Solution 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension- PEONY Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01","primaryCompletion":"2019-01","completion":"2019-01","firstPosted":"2016-12-05","resultsPosted":"2024-03-15","lastUpdate":"2024-03-15"},"enrollment":370,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Open Angle Glaucoma or Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"DE-117","otherNames":[]},{"type":"DRUG","name":"Latanoprost ophthalmic solution","otherNames":["Xalatan"]}],"arms":[{"label":"DE-117 ophthalmic solution","type":"EXPERIMENTAL"},{"label":"Latanoprost ophthalmic solution 0.005%","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to investigate the intraocular pressure-lowering effect and the safety of DE-117 ophthalmic solution compared with Latanoprost ophthalmic solution in subjects with open angle glaucoma or ocular hypertension.","primaryOutcome":{"measure":"Mean Diurnal IOP at Month 3","timeFrame":"Month 3 (average of IOP at 3 time points: 09:00, 13:00, 17:00)","effectByArm":[{"arm":"DE-117 Ophthalmic Solution","deltaMin":17.5,"sd":0.25},{"arm":"Latanoprost Ophthalmic Solution 0.005%","deltaMin":16.8,"sd":0.25}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":1,"countries":["Singapore"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":185},"commonTop":["Conjunctival hyperaemia","Dry eye","Photophobia","Eye pain","Corneal thickening"]}}